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http://www.cityallergy.com

A systemic, immediate, hypersensitivity reaction produced by
immunoglobulin E (IgE-mediated) immunologic release of
mediators from mast cells and basophils (Lieberman, 2013).
Type 1 hypersensitivity reactions usually have an early and a
late phase. The early phase is generated by mast cell and
basophil mediators that also initiate the later phase events
(Casey, 2013).
Most cases of anaphylaxis are immunoglobulin E (IgE)–
mediated. Antibodies exposed to a particular allergen attach to
mast cells and basophils, resulting in their activation and
degranulation (Arnold, & Williams, 2011).
A variety of chemical mediators are released including
histamine, heparin, tryptase, kallikrein, platelet-activating factor,
bradykinin, tumor necrosis factor, nitrous oxide, and several
types of interleukin (Arnold, & Williams, 2011).

Significance of Pathophysiology











Histamine is the main component of granules and, once released, acts mainly via H1 receptors to trigger vasodilation and
increased vascular permeability (Casey, 2013).
H1 receptor activation also causes smooth muscle contraction in the airways, leading to bronchospasm, and in the GI
tract causing nausea, vomiting, bloating abdominal cramps and diarrhea (Casey, 2013).
Vasodilation of skin vessels may induce urticaria (Casey, 2013).
Vasodilation in the soft tissues in the throat and upper airways (angioedema) (Casey, 2013).
Histamine stimulation of H1 receptors in local nerve endings causes pruritus and sometimes pain (Casey, 2013).
Prostaglandins and leukotrienes are even more potent vasodilators and broncho-constrictors than histamine. The
combined vasodilator effects may be sufﬁcient for loss of up to 35 per cent of circulating volume within 10 minutes
(Casey, 2013).
Leukotrienes act as signals to recruit late-phase cells (potential cause for biphasic reaction) (Casey, 2013).
Late-phase responses are due to recruitment of other cells, especially eosinophils, neutrophils and lymphocytes; which
produce cytokines that promote further inﬂammation and also damage surrounding tissue (Casey, 2013).
Epinephrine is a sympathomimetic – it activates the sympathetic nervous system (Casey, 2013).

Actions of Epinephrine

Alpha-1 receptor binding causes systemic vasoconstriction, countering the effects of histamine
and preventing or relieving hypotension, loss of circulating volume, and angioedema that might
obstruct the airways (Casey, 2013).

Beta-1 adrenergic receptor binding increases heart rate and cardiac output to help manage
shock (Casey, 2013).

Beta-2 binding causes bronchodilation and also reduces the release of histamine from mast cells
(Casey, 2013).

Symptoms
Ohio Department of Health
SYMPTOMS
For Any of the Following Symptoms
(Stay with individual. Never leave alone.)
One or more of the following:
LUNG: Short of breath, wheezing, repetitive coughing
HEART: Pale, blue, faint, weak pulse, dizzy, confused
THROAT: Tight, hoarse, trouble breathing and/or
swallowing/speaking
MOUTH: Significant swelling of the tongue and/or lips
SKIN: Many hives over body, widespread redness
GUT: Repetitive vomiting, severe diarrhea
NEURO: Felling something bad is about to happen, anxiety, fear
https://www.odh.ohio.gov/odhprograms/chss/schnurs/guidepub.aspx












Pathophysiologic Process: Case Study
A 31-year-old anxious appearing woman presents to the emergency department
triage desk. The patient states that she thinks she is having an allergic reaction. She
further states that she is aware of an existing peanut allergy that was described to her
in childhood by a parent. The patient states that she is very cautious to not ingest any
peanut containing products, so she has never experienced any allergy symptoms that
have required medical attention. The patient has visible urticarial on her arms and
exposed neck-line, which she states “itches”. The patient states that she feels a
tightness in her chest, and a sensation of nausea; however, she has not “thrown-up”.
Initial vitals are as follows: respirations of 20, Lung sounds are clear but diminished
in the bilateral bases, blood pressure 85/50, oral temperature 37.6 C, heart rate of
100 with a thready radial pulse, pulse ox saturation of 93% on room air, pupils are
equal, round, and reactive to light at 3 mm., oral mucosa appears dry with mild to
moderate edema. She states her last menstrual period was approximately 4 weeks
ago, has not experienced any changes in her bowel or bladder habits, has not been
otherwise sick. The patient denies illicit drug and/or tobacco use, and drinks 1-2
alcoholic drinks per week. Lastly, the patient describes the only other change in her
daily habits is that yesterday she started a “very-strenuous” physical training regimen
for an upcoming athletic event, that she wishes to participate in.

Implications for Nursing Care


Conclusion

Introduction
Anaphylaxis is an emergent, life-threatening condition and quick
provider response is imperative. Symptoms of anaphylaxis may include, but are not
limited to, difficulty in breathing, an abrupt fall in blood pressure, edema, hives,
itching, and gastrointestinal cramping (McCance, & Heuther, 2014, p.1675). A study
published in the Journal of Allergy and Clinical Immunology (JACI) indicates the
prevalence of anaphylaxis in the general population is at least 1.6%, and possibly
affecting as many as 1 in 20 in specific populations (Wood, Camargo, Lieberman,
Sampson, Schwartz, Zitt, & Simons, 2014). When a patient has an acute and sever
anaphylactic response, that patient’s healthcare provider must be ready to
immediately act using an expert level of awareness, and evidence based-knowledge.
This paper is intended to cultivate a spirit of inquiry into, and a better understanding
of anaphylaxis. Every provider must be able to recognize anaphylaxis; but, exceptional
providers will recognize anaphylactic: signs, symptoms, underlying pathophysiology,
significance of the pathophysiology, significance of the required nursing care, and
implications for future management of the disease process.

Food allergy is the most common trigger of anaphylaxis
in children and adolescents, however other triggers
include, but are not limited to drug allergies, chemicals,
insect venom, and exercise. (Gupta, 2014).
Most patients make at least one mistake in administration
of autoinjectors; furthermore, most patients make
multiple mistakes and will not benefit from selfadministration of the potentially life-saving treatment if
the need arises (Bonds, Asawa, & Ghazi, 2015).
A large percentage of patients use epinephrine injectors
incorrectly; therefore, it is essential that healthcare
providers demonstrate for patients the proper use of an
epinephrine autoinjector and confirm patient proficiency
(Campbell, Li, Nicklas, & Sadosty, 2014).

Engaging Patients in Their Own Preparedness and Therapy
Action Plans:

Provide an anaphylaxis plan of action that is illustrative
and written in an understandable form

Provide the plan of action to patients, parents, caretakers,
and schools

Evaluate the content of the written plan of action and
determine the understandability

Ensure that patients, parents, caretakers, and schools understand:

The significance of risk

The possibility of increasing severity with subsequent
exposure

Relevant avoidance measures

Early recognition of symptoms

Appropriate treatment with Epinephrine, or an
Epinephrine autoinjector

Improve adherence through tailored self-management plans, one-onone counseling sessions, or telephone follow-up. Follow-up
discussions after a visit should include the following questions:

Did you pick up your medicine?

Do you have any questions about what we discussed
regarding how to use the medicine and why you need it?

Did you have any managed care insurance problems?
Bennett, Fromer, & Hayden, 2014













The timely administration of
epinephrine is essential to the effective
treatment of anaphylaxis, and such
administration is dependent on
correctly diagnosing anaphylaxis
(Campbell, Li, Nicklas, & Sadosty,
2014).
No absolute contraindication to
epinephrine use in the setting of
anaphylaxis (Campbell, Li, Nicklas, &
Sadosty, 2014).
Epinephrine auto-injector education is
essential
Anaphylaxis can progress rapidly from
mild manifestations involving one
organ-system to severe involvement of
multiple organ-systems (Campbell, Li,
Nicklas, & Sadosty, 2014).
Patient’s having been treated for
anaphylaxis whom are not candidates
for hospital admission must be
monitored in the emergency
department for at least several hours
given the risk for a biphasic reaction,
marked by reoccurrence of
anaphylaxis symptoms after an initial
remission (Grossman, Baumann,
Garcia Peña, Linares, Greenberg, &
Hernandez-Trujillo, 2013).
Education on patient specific
anaphylactic associated triggers is
essential
Anaphylaxis is associated with
significant morbidity and can be fatal
(Nowak, Farrar, Brenner, Lewis,
Silverman, Emerman, & Wood, 2013).
A patient can be experiencing an
anaphylactic reaction without shock
(Nowak, Farrar, Brenner, Lewis,
Silverman, Emerman, & Wood, 2013).
Anaphylaxis is a long term diagnosis,
that does not end with discharge from
the emergency department (Nowak,
Farrar, Brenner, Lewis, Silverman,
Emerman, & Wood, 2013).

http://www.iainfoctr.com
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